Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen
hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for
the ideal oestrogen therapy
Author:
Douxfils Jonathan,Foidart Jean-Michel,Gaspard Ulysse,Chatel Guillaume,Taziaux Mélanie,Jost Maud,Gérard Céline,Morimont Laure
Publisher
Termedia Sp. z.o.o.
Subject
Obstetrics and Gynecology,Endocrinology, Diabetes and Metabolism